Skip to main content
  • Advertise
    Want to Advertise with Us?
    Conquer welcomes advertising and sponsorship collaborations with reputable companies offering high-quality products and services to people affected by cancer.
  • Affiliated Brands
    Academy of Oncology Nurse & Patient Navigators
    The Academy of Oncology Nurse & Patient Navigators (AONN+) is the largest national specialty organization dedicated to improving patient care and quality of life by defining, enhancing, and promoting the role of oncology nurse and patient navigators. Our organization of over 8,900 members was founded in May 2009 to provide a network for all professionals involved and interested in patient navigation and survivorship care services to better manage the complexities of the cancer care treatment continuum for their patients. We view our organization as one consisting of “professional patient advocates” and, to that end, we support and serve our members.
    Journal of Oncology Navigation & Survivorship
    The Journal of Oncology Navigation & Survivorship (JONS) promotes reliance on evidence-based practices in navigating patients with cancer and their caregivers through diagnosis, treatment, and survivorship. JONS also seeks to strengthen the role of nurse and patient navigators in cancer care by serving as a platform for these professionals to disseminate original research findings, exchange best practices, and find support for their growing community.
    The Oncology Nurse-APN/PA
    The Oncology Nurse-APN/PA (TON) provides coverage of the wide spectrum of oncology-related events, trends, news, therapeutics, diagnostics, organizations, and legislation that directly affect hematology/oncology nurses and advanced practitioners involved in healthcare delivery and product utilization. The scope and coverage include a unique presentation of news and events that are shaping the care of patients with cancer.
  • Healthcare Providers
  • Contribute

April 2019 Vol 5 No 2

A Taboo Cancer: Anal Cancer Was Easy to Treat, but Tough to Talk About
When Page Leggett found out that HPV infection, a common sexually transmitted disease, had caused her anal cancer, she relied on her incredible sense of humor to get through that experience and start a conversation about this taboo topic. Read More ›

Facing an Advanced-Stage Cancer Should Not Be Financially Devastating
Adam Balinsky, President of Fifth Season Financial, discusses the company’s Funds for Living and Giving program, which provides financial help for people with advanced cancer by leveraging their existing life insurance policy. Read More ›

In Search of Guidance & Inspiration
Tom Galioto, a volunteer at his local Tri-Cities Cancer Center in Kennewick, Washington, has always recognized the importance of maintaining a positive outlook and a sense of humor even in the face of a cancer diagnosis. He shares some of his favorite “inspirology” sayings, offering guidance and levity in making your challenges a little lighter. Read More ›

Your Navigator Will Help You Gain a Sense of Control Over Cancer
Longtime nurse navigator Sharon Gentry describes how a nurse navigator will help ensure you get the best possible care during your treatment and beyond. The article includes useful sources and a handy chart for easy reference. Read More ›

The Gift of Life After Skin Cancer: From Surgeon to Being a Patient
After a lifetime of treating patients, Dr. David Crouch understood his own illness left little room for optimism as skin cancer returned again and again. As a last resort, he joined a clinical trial of a new immunotherapy that provided him a new lease on life. Today, after 2 years in remission, his mission is to educate people about this cancer and this immunotherapy. Read More ›

Why Proactive Lung Cancer Screening Can Save Lives

Imbruvica as First Treatment a New Standard in Older Patients with Chronic Lymphocytic Leukemia
Results of a recent study showed that using the targeted therapy Imbruvica (ibrutinib) as the first treatment in older adults with CLL was better than the combination of chemotherapy plus immunotherapy in slowing the progression of the disease. Read More ›

Trazimera a New Biosimilar for HER2-Positive Metastatic Gastric or Gastroesophageal Junction Cancer, or Breast Cancer

Lonsurf Approved for Metastatic Gastric or Gastroesophageal Junction Cancer
In February 2019, the FDA approved Lonsurf for the treatment of patients with metastatic gastric (stomach) cancer or gastroesophageal junction adenocarcinoma. This drug was previously approved only for patients with metastatic colorectal cancer. Read More ›

A Spring to Crush Stigmas

Page 1 of 2